Timolol-Latanoprost PF Solution — Class II drug recall D-1132-2017
Terminated recall by ImprimisRx CA, Inc., dba ImprimisRx, reported 2017-09-13, distributed nationwide. Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by th
| Recall number | D-1132-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | ImprimisRx CA, Inc., dba ImprimisRx, Irvine, CA, United States |
| Recall initiated | 2017-06-23 |
| Classified | 2017-09-07 |
| Reported by FDA | 2017-09-13 |
| Terminated | 2019-01-14 |
| Distributed | Nationwide (US) |
| Quantity | 16 bottles |
| Reason classes | undeclared allergen, labeling |
Product
Timolol-Latanoprost PF Solution (0.5-0.005)%, Ophthalmic Drops, Sterile 5ml Bottle, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA
Reason for recall
Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1132-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.